🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology

RecruitingNAAges 18 Years - anyAllMedical University Innsbruck
NCT04662970 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The principal aim is to analyze total left and right ventricular activation time in different CRT device programming algorithms (SyncAV) measured by non-invasive electrophysiology

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients after successful implantation of a CRT-D or CRT-P device in whom a cardiac magnetic resonance examination is possible and the device is equipped with the SyncAV® programming software * left bundle branch block before CRT implantation * PQ interval ≤ 250 ms before implantation Exclusion Criteria: * high-grade AV block * any contraindication concerning a safe CMR performance including claustrophobia * terminal heart failure (NYHA IV) or cardiac decompensation * life expectancy \< 1 year * women with child-bearing potential, pregnancy * drug abusus
💊

What it tests

  • Device programming
📍

Where

1 site
Medical University Innsbruck
Innsbruck, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy